DXM + Diphenhydramine, dimenhydrinate, doxylamine

Group assessment

This PHI covers the named group; its members do not have separate PHI ratings.

PHI 4 to 6

https://dxm-atlas.org/en/interactions/diphenhydramine-dimenhydrinate-doxylamine/

Compare

Key points for this combination

Drowsiness, reduced alertness and anticholinergic effects. CYP2D6 inhibition is better supported for diphenhydramine. This means reduced activity of the enzyme. The supporting findings come from laboratory work and human interactions involving other substances; they do not allow the effect on DXM to be calculated [18].

General concepts in this text

Enzyme

A protein that helps chemical transformations in cells.

A transformation can build or break down a substance.

Sources: Enzyme

CYP2D6

One of the CYP enzymes involved in processing drugs.

Inhibition means reducing enzyme activity; it can change the processing of drugs.

Sources: CYP2D6

Antimuscarinic action

Blocking the action of acetylcholine at muscarinic receptors.

Muscarinic receptors are one type of receptor for acetylcholine, a chemical messenger.

Sources: Antimuscarinic action

How well is this understood?

Mechanism confidence: high

Confidence in the mechanism: high

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: low

Confidence in direct human evidence involving DXM: low

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method

How to read ratings and study limits

How do the substances interact?

Can the amount reaching the body change?

Mechanism: 2D6 — CYP2D6 metabolism (uncertain contribution)
ⓘ

CYP2D6

One of the CYP enzymes involved in processing drugs.

Inhibition means reducing enzyme activity; it can change the processing of drugs.

Sources: CYP2D6

How can the effects add up?

Mechanism: AM — Antimuscarinic effects
ⓘ

Antimuscarinic effects, including impaired sweating and peripheral toxicity

Mechanism: SED — Sedation
ⓘ

Additive sedation, impaired consciousness or protective reflexes, and possible respiratory consequences

Sources

Check the review’s wording

Sedation and anticholinergic effects; CYP2D6 contribution better supported for diphenhydramine [18]

Antihistamines: context from the review

Diphenhydramine’s CYP2D6 inhibition is supported by in vitro findings and human interactions involving other substrates; the effect on DXM cannot be calculated from those observations. Other sedating antihistamines need not share the same CYP effect to create hazards [18]. Historical warnings about terfenadine cannot be transferred to all modern nonsedating antihistamines.

Read the full passage

Combination row in the review: 2D6 — CYP2D6 metabolism? (uncertain contribution); AM — Antimuscarinic effects; SED — Sedation

Related entries

Reference

Open the source and related combinations →